E

Entrada Therapeutics

Develops intracellular therapeutics using endosomal escape

Clinical Scientist - Consultant

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeBoston, MA, USANo salary listed

About the Job

Requirements

  • A Ph.D., PharmD, MD, Nursing, or Clinical Master’s degree in a scientifically relevant field, with at least 6 years of clinical development experience within the biotechnology or pharmaceutical industry.
  • Proven understanding of clinical development processes to serve as a subject matter expert for phase 1–3 clinical studies.
  • Previous experience identifying trends and setting risk mitigation strategies in partnership with Medical teams within clinical studies.
  • Demonstrated experience in the design and execution of clinical trials and a strong understanding of GCP/ICH guidelines and regulatory expectations.
  • Skilled in the Microsoft suite and innovative data review tools, such as patient profiles and report-generating tools.
  • Ability to interpret complex data and communicate clearly with scientific and non-scientific stakeholders.
  • Strong data analysis, data visualization, and communication skills, with the ability to write clear, accurate, and concise documents, construct informative figures, and present to diverse audiences.
  • Able to work 40 hours per week in this US-based remote contract position and travel to the Boston headquarters at least quarterly.

Responsibilities

  • Support interpretation of clinical data to generate high-quality summaries and insights for regulatory filings, publications, and scientific communications.
  • Collaborate cross-functionally with Medical Directors, Clinical Operations, Data Management, Biostatistics, and Business Operations to help drive execution across clinical phases.
  • Partner with Medical Directors to lead or support the authoring of selected sections of clinical study reports.
  • Support real-time data review, identify trends in safety and efficacy data, assess protocol compliance including protocol deviation reviews, and escalate issues to Medical Monitors where appropriate.
  • Identify scientific or clinical quality issues to discuss with principal investigators and study sites, partnering with the study team and GCP quality team members for escalations as needed.
  • Consult on the design of study-specific case report forms and author study-specific sections of CRF completion guidelines, ensuring CRFs are aligned with study requirements during user acceptance testing.
  • Perform safety and efficacy reviews in preparation for DMC in conjunction with the Medical Director and other internal stakeholders, analyzing trends within and across programs.
  • Collaborate with Business Operations and Data Management to lead development and innovation of the department’s clinical data technology access, retention, and visualization strategy to support trend identification across programs.
  • Support innovation and strategy for integrating new tools and technologies into phase 1–3 clinical studies.

Desired Qualifications

  • Experience in rare disease or neuromuscular disease is strongly preferred.

About the Company

Entrada Therapeutics

Develops intracellular therapeutics using endosomal escape

Entrada Therapeutics focuses on developing a new class of medicines to treat devastating diseases by delivering therapies inside cells. Its core technology, the Endosomal Escape Vehicle (EEV) platform, helps drugs escape from endosomes—cellular compartments that often trap or degrade treatments—so they can reach intracellular targets. The product pipeline centers on EEV-therapeutics, including candidates for Duchenne muscular dystrophy and other neuromuscular diseases, with ENTR-601-45 currently cleared by UK and EU regulators to begin clinical trials. What sets Entrada apart is its explicit emphasis on enabling intracellular delivery to access targets that were previously hard to treat, using a platform-agnostic delivery approach that can work with a range of therapeutics such as oligonucleotides. The company’s goal is to advance multiple EEV-therapeutics through clinical development to address rare and other hard-to-treat diseases and reach patients who need new treatment options.

Company size
201-500
Company stage
IPO
Headquarters
Boston, MA
Founded
2016

Recently Posted Jobs

Explore more opportunities at Entrada Therapeutics

See more jobs